Cyrus Reporter

Outreach to public office holders relating to plans to develop, liquified propane gas (LPG) export terminals on the west coast of British Columbia Outreach to public office holders on issues involving the development of new marine infrastructure to support the export of Natural Gas Liquids

Investigating opportunities for funding to establish processing facilities Engagement on proposed front of package labelling requirements

Engagement with Government regarding potential collaboration and funding opportunities with regard to the development of Avalon's new wave of display technology Engagement with Government regarding potential collaboration and funding opportunities with regard to the development of Avalon's new wave of display technology

Working with our Industry Associations (Innovative Medicines Canada and BIOTECanada) to provide industry recommendations on Canada's Biomanufacturing and Life Sciences Strategy, National Pharmacare, Intellectual property as well as pricing reforms (PMPRB) Science and Technology Strategy, advocating for the development of a Biopharma sector in support of more research & development in Canada. R&D requirements set forth through the Patent Medicines Pricing Review Board (PMPRB) Patent Medicines Pricing Review Board reforms, regarding both the revised regulations and draft guidelines Patented Medicines (Notice of Compliance) Regulations as it relates to regulation of intellectual property for therapeutic products. Novartis is working with our industry associations (Innovative Medicines Canada and BIOTECanada) to provide a written response to Guideline consultation process and will provide our own corporate submission. Federal Public Drug Plans, with respect to the reimbursement of drug products for the Federal plan beneficiaries Federal Innovation agenda. Working with our Industry Associations (Innovative Medicines Canada and BIOTECanada) to ensure that innovative medicines, and our contribution to Research and Development in Canada are part of the consultation process in the development of this new innovation agenda. Canadian Agency for Drugs and Technologies in Health (CADTH), including Therapeutic Reviews and the Common Drug Review as it relates to reimbursement recommendations for decision-making process and framework.

Arrange meetings and inform public office holders regarding the company’s mission to launch, deploy and operate a constellation of 258 satellites in Low Earth Orbit (called Pulsar), and offer the navigation signals broadcast from these satellites as a commercial service. This will including exploring funding opportunities through the Defence Industrial Strategy, Strategic Response Fund

Renewable Energy: Role of electrification to achieve GHG reductions (how to get to net zero by 2050) and increased renewable energy, opportunity to advance reconciliation through renewable energy, opportunity leverage renewable energy to achieve a just coal transition, challenges/market barriers to bringing projects to market. The values and added benefits that strategically developed renewable energy projects can offer. Incentive programs to accelerate GHG reductions and benefits of renewable energy strategy. Government policies related to tariffs on inputs into renewable infrastructure

Engagement with Government of Canada regarding the upcoming G7 meeting in Kananaskis AB and opportunities to further economic reconciliation including infrastructure, housing and economic development Engagement with Government of Canada regarding opportunities to incent First Nations led housing initiatives

Exploration of potential federal support for Ontario Pumped Storage Project To discuss skills development requirements for energy infrastructure projects. Representations, comments and discussions regarding the proposed introduction of an investment tax credit for renewable energy projects. Representations, comments and discussions regarding the proposed introduction of an investment tax credit for capital invested in carbon, capture, utilization and storage (CCUS) projects. Discussions on Federal Emissions Policy